The increased risk for venous thromoboembolism after surgery among patients with rheumatic disease appears to trace to those conditions with a clotting component. However, joint surgery in general has a high risk of this complication.
The UK government's health assessment agency has found that combinations of traditional drugs offer results for rheumatoid arthritis not inferior to those of tumor necrosis factor inhibitors, although the latter work more quickly.
Reviews by a rheumatologist and an oral health specialist spell out the evidence that links periodontal disease and rheumatoid arthritis. Can effective treatment of teeth and gums alter the course of the rheumatic disease?
The American College of Rheumatology has issued a public statement of concern about the need for policy changes, studies, and post-marketing vigilance in the wake of FDA's approval of the first US biosimilar.
Patients with rheumatoid arthritis have double or triple the usual risk of cardiovascular disease. Guidelines give little advice about how to measure or reduce it. Can assessment tools be made more specific?